Surrogacy in South Korea: Legal Framework and Limits
The short answer
South Korea is not a jurisdiction in which intended parents should assume that a surrogacy arrangement is legally available merely because a clinic offers assisted reproduction or because the parties call the arrangement altruistic. The strongest current judicial position is that an agreement under which a woman becomes pregnant and gives birth through assisted reproductive technology in order to hand the child to other people is void under Article 103 of the Civil Act, which invalidates legal acts contrary to good morals or public order. The Supreme Court confirmed that principle on 24 April 2025. A separate Seoul Family Court decision in 2018 had already held that gestational surrogacy was not permitted under the interpretation of Korean law and upheld the refusal to record the intended mother as the child's mother on the facts before it.
Separate questions include contract validity, payments, embryo and gamete handling, legal parentage, birth registration, adoption, nationality and immigration. Contract invalidity does not automatically resolve the child's later status or every financial claim between adults.
What the legal framework does—and does not—say
The central sources are the Civil Act, the Bioethics and Safety Act, the Act on Registration of Family Relations and court decisions applying them. The sources do not set out a dedicated surrogacy licensing pathway, a clear statutory exception for altruistic arrangements, or a mechanism by which a private agreement alone transfers legal parenthood to intended parents.
A gap in legislation is not permission. But it is also inaccurate to claim that every act related to surrogacy is expressly a crime. The clearest supported conclusion is civil invalidity of the agreement to deliver the child and of a birth mother's waiver of maternity rights. Other consequences depend on the conduct, evidence, participants, medical steps, payments and procedural posture.
Civil Act Article 103: why the agreement matters
Article 103 of the Civil Act provides that a juristic act whose content violates good morals or other social order is null and void. In the 2018 Seoul Family Court decision and the 2025 Supreme Court judgment, this general civil-law provision was applied to surrogacy agreements. The courts did not treat the contract as an ordinary services agreement that could simply be enforced according to its terms. The 2025 Supreme Court explained that an agreement to hand over a child born through assisted reproductive technology objectifies the woman's body and the child and disregards the emotional relationship formed through pregnancy and birth.
Intended parents should not assume that a signed contract gives them an enforceable right to require delivery of the child, a waiver of maternity, or a particular parentage entry. Nor should the birth mother assume that a contractual waiver removes rights arising from childbirth. The contract may be evidence of the parties' actions and intentions, but evidence is not enforceability. Payments already made, expenses, alleged misrepresentation, damages and restitution require separate analysis; invalidity does not guarantee repayment or determine every financial remedy.
The 2018 Seoul Family Court decision
In its decision dated 9 May 2018, case 2018브15, the Seoul Family Court considered a married couple who had an embryo created from their own gametes transferred to another woman. The child was born in the United States. The foreign birth certificate identified the woman who gave birth as the mother, while the intended parents sought to register the intended mother in Korea. The registration authority refused because the mother's identity in the report did not match the birth certificate. The court upheld the refusal.
The court reasoned that Korean birth-registration rules verify childbirth and align legal maternity with the woman who gave birth. It also concluded that gestational surrogacy was not permitted under its interpretation of Korean law and that the agreement was void under Article 103. This was a Seoul Family Court decision, not a Supreme Court judgment. It is important for maternity and registration, but must be described accurately by court level and facts.
The Supreme Court judgment of 24 April 2025
In Supreme Court Decision 2022므15371, decided on 24 April 2025, the carrier had provided both her egg and the uterus. The reported arrangement included payment of KRW 80 million. The Supreme Court held that an agreement to give the child to other people after birth was invalid under Civil Act Article 103. It also held that an agreement by the woman who gave birth to relinquish all rights as the child's mother was invalid. Where the woman who gave birth is genetically related to the child, the court stated that she is the child's mother even if the birth occurred under an invalid surrogacy agreement.
The procedural result matters. The Supreme Court set aside the lower appellate decision and remanded the case. It explained that a parentage action may exceptionally be rejected as an abuse of process if restoring the legally true parent-child relationship would seriously harm the child's welfare. This narrow, fact-specific exception does not mean a surrogate automatically wins or loses. Relevant factors include how the legal family relationship arose; the duration and substance of the child's relationship with the people raising the child; likely harm to the child and legal parents; the claimant's motives and potential harm if the claim is rejected; and effects on others.
The 2025 case directly concerned a woman who provided the egg and gave birth. It should not be presented as resolving every case in which intended parents' gametes are used and a genetically unrelated woman carries the embryo. The 2018 Seoul Family Court decision addressed that gestational scenario. Together, the decisions create serious legal obstacles to both traditional and gestational surrogacy, while the remedy in an individual case still depends on its facts and procedure.
Commercial and non-commercial models
The risk does not disappear because an arrangement is called altruistic or no fee is paid. The 2025 Supreme Court focused on the agreement to hand over the child and the invalid waiver of maternity, not just payment. The reviewed primary sources do not establish a clear safe harbour for unpaid arrangements.
The payment analysis must remain precise. Article 23(3) of the Bioethics and Safety Act separately prohibits providing or using embryos, eggs or sperm for money, property benefit or other consideration, and prohibits inducing or arranging those transactions. It concerns embryos and gametes; it should not be misdescribed as a blanket statutory offence covering every payment to a carrier. Whether a particular payment, intermediary service or medical step breaches another rule requires fact-specific advice. Civil invalidity and criminal or administrative liability are distinct.
| Issue | Current legal position | Practical consequence |
|---|---|---|
| Agreement to hand over a child | Void under Civil Act Article 103 in the 2018 and 2025 decisions. | Do not rely on the contract to compel transfer or waive maternity. |
| Unpaid or altruistic arrangement | No clear statutory safe harbour exists. | No payment does not itself make the agreement enforceable. |
| Payment for embryos or gametes | Bioethics Act Article 23(3) prohibits provision or use for consideration and related inducement or arranging. | Do not conflate this rule with a blanket ban on every payment to a carrier. |
| Clinic and consent | Article 22 requires designated embryo-producing medical institutions; Article 24 requires written consent. | Verify designation, consent forms and the exact medical steps. |
| Parentage and foreign records | Birth and birth evidence matter; a foreign certificate does not automatically settle Korean parentage. | Plan parentage, registration, adoption and travel separately. |
Assisted reproduction, embryos and gametes
The Bioethics and Safety Act regulates important aspects of assisted reproduction but is not a complete surrogacy code. Article 22 requires a medical institution that collects or preserves eggs or sperm for IVF, or fertilises them to create embryos, to be designated by the Minister of Health and Welfare as an embryo-producing medical institution. Clinic advertising is not proof of that designation. Before treatment, verify the clinic's current status with the competent Korean authority and obtain a written description of the proposed procedure.
Article 24 requires written consent from relevant persons before eggs or sperm are collected for embryo creation and requires the institution to explain the consent matters. Article 23 limits embryo creation to pregnancy purposes and prohibits specified conduct, including gamete selection for sex selection, fertilisation using a deceased person's gametes, and use of a minor's gametes subject to the statutory exception for a married minor seeking a child. Article 23(3) also prohibits providing or using embryos, eggs or sperm for consideration, or inducing or arranging such transactions.
These rules do not themselves establish that every IVF procedure connected to surrogacy is lawful or unlawful. Their application depends on the exact materials, consent, parties, clinic, payment and procedure. In particular, payment for gametes or embryos must be distinguished from reimbursement of documented medical expenses or payment to a carrier; do not assume that those categories are legally identical. A clinician's willingness to perform a procedure is not a ruling on contract validity, parentage, birth registration or the child's nationality.
Who is the legal mother—and what about the intended father?
The 2018 Seoul Family Court treated childbirth as the central criterion for identifying the legal mother under the rules before it. In 2025, the Supreme Court confirmed that where the birth mother is also genetically related to the child, she is the mother despite the invalid agreement. Intended mothers should not assume that genetic connection, payment of costs, a contract or day-to-day care automatically makes them legal mothers from birth.
The intended father's status must be assessed separately. The Civil Act contains rules on the husband's presumption of paternity for a child conceived during marriage, as well as recognition and judicial determination of parentage. Those rules have their own conditions; DNA evidence or a surrogacy contract is not a universal substitute. Marriage to the birth mother, use of the intended father's sperm, registration details and the place of birth may matter. The 2018 decision mentioned adoption as a possible route for the intended mother in that case, not a guaranteed solution; eligibility, consent, child welfare, current adoption law and the competent court must be checked.
Birth registration in Korea
Article 44 of the Act on Registration of Family Relations governs information to be included in a birth report and the supporting birth evidence. Under the current text effective from 2 October 2026, the Act requires a birth report within one month and lists the child's identifying details, the date and place of birth, and parent information among the required particulars. It also addresses the documents that may support a report, including a birth certificate or a document issued by a competent domestic or foreign authority proving the birth.
A foreign birth certificate does not itself settle whether Korea must register an intended parent as a legal parent. In 2018, the court upheld rejection where the mother's name in the birth report differed from the certificate and treated the woman who gave birth as the mother. That case concerned a particular foreign-born child and record; current rules and facts must be reviewed in any new case. If registration is refused, preserve the application, birth record, translations, proof of filing and written reasons. Do not correct a mismatch with inaccurate information; promptly obtain Korean family-law advice on review or court proceedings and the child's status while the dispute is pending.
Foreign arrangements, nationality and travel
An arrangement carried out abroad does not eliminate Korean-law issues for Korean intended parents or a child whose status must be addressed in Korea. The 2018 case involved a child born in the United States, yet Korean registration remained disputed. The law of the treatment or birth location may govern local issues, while Korean law may govern the contract's effect, family-register entries or proceedings before Korean authorities. No single foreign document should be assumed to resolve every issue.
Analyse separately: (1) validity of the arrangement and payments under the law where they occurred; (2) legal parentage under each relevant law; (3) recognition in Korea of a foreign birth certificate, parentage order or judgment; (4) the child's nationality; and (5) passport, visa or travel-document eligibility. Genetic connection, place of birth, contract or foreign judgment may be evidence but do not automatically decide every issue. Before overseas treatment, ask Korean counsel to review the jurisdiction, governing law, parentage and adoption routes, expected documents, and a plan if the foreign record names the carrier as mother.
Practical risks and possible legal routes
The most important risk is a mismatch between the family the adults intended to create and the legal family relationship that the authorities recognise. The contract may be void; the birth mother may retain legal maternity; an intended mother's name may not be accepted in a birth report; and a genetic relationship may require a separate legal step to establish the intended father's status. The child may also be affected by delay, uncertainty about documents, competing proceedings, privacy issues or a dispute between adults. These risks are not resolved by calling the arrangement altruistic or by keeping the contract confidential.
Steps depend on timing. Before conception, pause plans that assume the contract is enforceable and obtain written Korean-law advice. After treatment but before birth, review medical records, consents, genetic relationships, proposed birth documents and applicable foreign law. After birth or refusal of registration, urgent steps may include securing accurate official records, reviewing the written refusal, establishing parentage, assessing adoption or court proceedings, and protecting the child's civil status. Preserve messages and payment records; do not submit false information.
A practical checklist before taking the next step
1. Identify all countries and participants: intended parents, carrier, any egg or sperm provider, clinic and intermediary. Record who provides each gamete and who will give birth. Genetic, gestational, intended and legal parent are not interchangeable categories.
2. Before signing, paying or starting treatment, obtain current Korean-law advice on Article 103, the 2018 Seoul Family Court decision and the 2025 Supreme Court judgment. Ask the lawyer to distinguish current law, lower-court reasoning and questions still uncertain on your facts.
3. Verify the clinic's designation under Article 22. Request the Article 24 consent forms, a description of embryo/gamete handling and a transparent payment breakdown. Separate compensation, medical-expense reimbursement, agency fees and payments for gametes or embryos.
4. Plan parentage and registration before conception. Confirm what documents the hospital and foreign authority will issue, whose name will appear as mother, whether Korean registration is planned and which legal route may apply to each intended parent. Do not assume adoption or recognition is automatic.
5. If the child is already born, preserve the original birth record, medical and genetic records, consents, contracts, payment evidence, translations and authority correspondence. If registration is refused, obtain written reasons and promptly consult Korean family-law counsel. Do not submit inaccurate information, alter records informally or publicise the child's private history.
Conclusion
As of 23 October 2026, the safest accurate description is that South Korea presents serious legal barriers to surrogacy agreements. The courts have treated agreements to deliver a child born through assisted reproduction, and waivers of the birth mother's parental rights, as void under Civil Act Article 103. The 2018 Seoul Family Court decision is directly relevant to gestational surrogacy and Korean birth registration; the 2025 Supreme Court judgment is the controlling high-court authority on the invalidity of a surrogacy agreement and waiver, and on maternity where the birth mother is genetically related to the child.
Do not convert that conclusion into an unsupported claim that every related act is a crime, that unpaid arrangements are exempt, or that all parentage disputes have a predetermined outcome. The law governing clinic activity, payments for gametes or embryos, paternity, adoption, birth registration, nationality and foreign judgments must be considered separately. A case-specific review by Korean family-law counsel is essential before action and particularly urgent when a child has already been born or a registration has been refused.
Primary legal sources
- S1: Supreme Court Decision 2022므15371, 24 April 2025 (official Korean judgment)
- S2: Seoul Family Court Decision 2018브15, 9 May 2018 (official Korean judgment)
- S3: Civil Act, Article 103 (current Korean text)
- S4: Bioethics and Safety Act, Article 22 (current Korean text)
- S5: Bioethics and Safety Act, Article 23 (current Korean text)
- S6: Bioethics and Safety Act, Article 24 (current Korean text)
- S7: Act on Registration of Family Relations, Article 44 (text effective 2 October 2026)
- S8: Civil Act, Article 844 (current English-language text)








